Navigate GxP Compliance in the Cloud with Confidence
Master SaaS GxP compliance with risk-based computer system validation (CSV) aligned to GAMP 5, FDA,…
Certara2026年3月6日
ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success
Optimize ADC First-in-Human Dose Selection with model-informed strategies and exposure–response insights to design safer, more…
Certara2026年3月3日
Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit)
This webinar introduces the Phoenix IVIVC Toolkit, showing how to perform BE analysis and build…
Certara2026年2月27日
On Rare Disease Day 2026, Certara experts share how cross-functional innovation, regulatory strategies for rare…
Certara2026年2月26日
Start right, finish strong: Antibody-drug conjugate (ADC) studies for success
Learn how to build regulatory-ready first-in-human (FIH) dose strategies for antibody-drug conjugates (ADCs). Discover how…
Certara2026年2月23日
